198 related articles for article (PubMed ID: 33686797)
1. T helper 17 cells: A new actor on the stage of type 2 diabetes and aging?
Chang YC; Hee SW; Chuang LM
J Diabetes Investig; 2021 Jun; 12(6):909-913. PubMed ID: 33686797
[TBL] [Abstract][Full Text] [Related]
2. Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation.
Bharath LP; Agrawal M; McCambridge G; Nicholas DA; Hasturk H; Liu J; Jiang K; Liu R; Guo Z; Deeney J; Apovian CM; Snyder-Cappione J; Hawk GS; Fleeman RM; Pihl RMF; Thompson K; Belkina AC; Cui L; Proctor EA; Kern PA; Nikolajczyk BS
Cell Metab; 2020 Jul; 32(1):44-55.e6. PubMed ID: 32402267
[TBL] [Abstract][Full Text] [Related]
3. The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus.
Abdel-Moneim A; Bakery HH; Allam G
Biomed Pharmacother; 2018 May; 101():287-292. PubMed ID: 29499402
[TBL] [Abstract][Full Text] [Related]
4. Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
Sun Y; Tian T; Gao J; Liu X; Hou H; Cao R; Li B; Quan M; Guo L
J Neuroimmunol; 2016 Mar; 292():58-67. PubMed ID: 26943960
[TBL] [Abstract][Full Text] [Related]
5. Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance.
Lee SK; Park MJ; Jhun JY; Beak JA; Choi JW; Rye JY; Jang JW; Bae SH; Yoon SK; Choi HJ; You YK; Cho ML; Choi JY
Front Immunol; 2020; 11():581728. PubMed ID: 33488583
[TBL] [Abstract][Full Text] [Related]
6. Electroacupuncture treatment of insulin resistance in diabetes mellitus.
Peplow PV
Acupunct Med; 2015 Oct; 33(5):347-9. PubMed ID: 26447107
[No Abstract] [Full Text] [Related]
7. Metformin attenuates autoimmune disease of the neuromotor system in animal models of myasthenia gravis.
Cui Y; Chang L; Wang C; Han X; Mu L; Hao Y; Liu C; Zhao J; Zhang T; Zhang H; Zhang Y; Liu Y; Zhao W; Wang J; Liu X; Sun B; Wang G; Kong Q; Han J; Li H
Int Immunopharmacol; 2019 Oct; 75():105822. PubMed ID: 31437793
[TBL] [Abstract][Full Text] [Related]
8. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
9. Elevated T-helper 2 cytokine levels in high fat diet-fed C57BL/6 mice are attenuated by short-term 6-week treatment with a combination of low-dose aspirin and metformin.
Mahlangu TJ; Dludla PV; Mxinwa V; Mkandla Z; Tiano L; Louw J; Mutize T; Nyambuya TM; Nkambule BB
Cytokine; 2020 Apr; 128():154999. PubMed ID: 32014718
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice.
Tahara A; Takasu T
Endocr Res; 2020; 45(2):147-161. PubMed ID: 31955626
[No Abstract] [Full Text] [Related]
11. Increased metformin dosage suppresses pro-inflammatory cytokine levels in systemic circulation and might contribute to its beneficial effects.
Amoani B; Sakyi SA; Mantey R; Laing EF; Ephraim RD; Sarfo-Katanka O; Koffie S; Obese E; Afranie BO
J Immunoassay Immunochem; 2021 May; 42(3):252-264. PubMed ID: 33444083
[TBL] [Abstract][Full Text] [Related]
12. Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs.
Alimoradi N; Firouzabadi N; Fatehi R
Biomed Pharmacother; 2021 Jul; 139():111662. PubMed ID: 34243629
[TBL] [Abstract][Full Text] [Related]
13. Insulin lispro reduces insulin antibodies in a patient with type 2 diabetes with immunological insulin resistance.
Asai M; Kodera T; Ishizeki K; Uebori S; Kashiwaya T; Itoh H; Makino I
Diabetes Res Clin Pract; 2003 Aug; 61(2):89-92. PubMed ID: 12951276
[TBL] [Abstract][Full Text] [Related]
14. Role of metformin in type II diabetes.
Epstein S
Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481
[No Abstract] [Full Text] [Related]
15. Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients.
Wang M; Chen F; Wang J; Zeng Z; Yang Q; Shao S
Clin Immunol; 2018 Dec; 197():77-85. PubMed ID: 30218707
[TBL] [Abstract][Full Text] [Related]
16. Myths about Insulin Resistance: Tribute to Gerald Reaven.
Kim SH; Abbasi F
Endocrinol Metab (Seoul); 2019 Mar; 34(1):47-52. PubMed ID: 30912338
[TBL] [Abstract][Full Text] [Related]
17. Mfn1 Deficiency in the Liver Protects Against Diet-Induced Insulin Resistance and Enhances the Hypoglycemic Effect of Metformin.
Kulkarni SS; Joffraud M; Boutant M; Ratajczak J; Gao AW; Maclachlan C; Hernandez-Alvarez MI; Raymond F; Metairon S; Descombes P; Houtkooper RH; Zorzano A; Cantó C
Diabetes; 2016 Dec; 65(12):3552-3560. PubMed ID: 27613809
[TBL] [Abstract][Full Text] [Related]
18. Metformin: a metabolic modulator.
Pietrocola F; Kroemer G
Oncotarget; 2017 Feb; 8(6):9017-9020. PubMed ID: 28122334
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of metformin in diabetes-related bone disease].
Kanazawa I
Clin Calcium; 2009 Sep; 19(9):1319-25. PubMed ID: 19721204
[TBL] [Abstract][Full Text] [Related]
20. Oxamate Enhances the Anti-Inflammatory and Insulin-Sensitizing Effects of Metformin in Diabetic Mice.
Wu MC; Ye WR; Zheng YJ; Zhang SS
Pharmacology; 2017; 100(5-6):218-228. PubMed ID: 28728159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
